Swine Flu Profits: Drug Companies To Reap Billions

Swine Flu Billions For Drug Companies

Some of the world's leading pharmaceutical companies are reaping billions of dollars in extra revenue amid global concern about the spread of swine flu.

Analysts expect to see a boost in sales from GlaxoSmithKline, Roche and Sanofi-Aventis when the companies report first-half earnings lifted by government contracts for flu vaccines and antiviral medicines.

Popular in the Community

Close

What's Hot